An open label phase II trial of glufosfamide: A β-D-glucose-linked isophosphoramide mustard given as 1-hour infusion in patients with advanced breast cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 646-646
Author(s):  
G. F. Tidmarsh ◽  
I. O. Kudajbergenova ◽  
S. N. Navrusov ◽  
V. V. Stepula
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Open Label ◽  
Open Label Phase ◽  
Isophosphoramide Mustard

Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2– Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial

2018 ◽  
Vol 18 (2) ◽  
pp. e197-e203 ◽  
Author(s):  
Tamar Safra ◽  
Bella Kaufman ◽  
Luna Kadouri ◽  
Noa Efrat (Ben-Baruch) ◽  
Larisa Ryvo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Endocrine Therapy ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Open Label ◽  
Open Label Phase

Phase-II Trial of Oral Idarubicin (4-Demethoxydaunorubicin) in Advanced Breast Cancer

1986 ◽  
Vol 9 (4) ◽  
pp. 236-238 ◽  
Author(s):  
H.-E. Wander ◽  
D. Meyer ◽  
P. Schuff-Werner ◽  
G.A. Nagel
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast

scholarly journals Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain

2004 ◽  
Vol 15 (2) ◽  
pp. 201-206 ◽  
Author(s):  
R. Colomer ◽  
A. Llombart-Cussac ◽  
A. Lluch ◽  
A. Barnadas ◽  
B. Ojeda ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Predictive Value ◽  
Phase Ii Trial ◽  
Extracellular Domain ◽  
Advanced Breast

Phase ii trial of D-Trp-6-LH-RH in advanced breast cancer

1987 ◽  
Vol 28 ◽  
pp. 100
Author(s):  
G. Mathe ◽  
R. Helling ◽  
J. Gastlaburu ◽  
M.L.. VoVan ◽  
G. Prévot ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Lh Rh

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

2014 ◽  
Vol 15 (7) ◽  
pp. 689-699 ◽  
Author(s):  
Ian E Krop ◽  
Sung-Bae Kim ◽  
Antonio González-Martín ◽  
Patricia M LoRusso ◽  
Jean-Marc Ferrero ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Trastuzumab Emtansine ◽  
Her2 Positive ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
Versus Treatment
Sign in / Sign up

Export Citation Format

Share Document